0001816233-24-000064.txt : 20240312 0001816233-24-000064.hdr.sgml : 20240312 20240312171305 ACCESSION NUMBER: 0001816233-24-000064 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 19 CONFORMED PERIOD OF REPORT: 20240312 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240312 DATE AS OF CHANGE: 20240312 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sharecare, Inc. CENTRAL INDEX KEY: 0001816233 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 851365053 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39535 FILM NUMBER: 24743314 BUSINESS ADDRESS: STREET 1: 255 EAST PACES FERRY ROAD NE STREET 2: SUITE 700 CITY: ATLANTA STATE: GA ZIP: 30305 BUSINESS PHONE: (404) 671-4000 MAIL ADDRESS: STREET 1: 255 EAST PACES FERRY ROAD NE STREET 2: SUITE 700 CITY: ATLANTA STATE: GA ZIP: 30305 FORMER COMPANY: FORMER CONFORMED NAME: Falcon Capital Acquisition Corp. DATE OF NAME CHANGE: 20200626 FORMER COMPANY: FORMER CONFORMED NAME: Falcon Capital Corp I DATE OF NAME CHANGE: 20200625 8-K 1 shcr-20240312.htm 8-K shcr-20240312
0001816233false00018162332024-03-122024-03-120001816233us-gaap:CommonClassAMember2024-03-122024-03-120001816233shcr:RedeemableWarrantsMember2024-03-122024-03-12


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (date of earliest event reported): March 12, 2024
SHARECARE, INC.
(Exact name of registrant as specified in its charter)
Delaware
001-39535
85-1365053
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
255 East Paces Ferry Road NE, Suite 700
Atlanta, Georgia 30305
(Address of principal executive offices)
Registrant's telephone number, including area code: (404) 671-4000
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading
Symbol(s)		Name of each exchange
on which registered
Common Stock, par value $0.0001 per share
SHCRThe Nasdaq Stock Market LLC
Warrants, each warrant exercisable for one share of common stock, each at an exercise price of $11.50 per shareSHCRWThe Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐




Item 8.01 Other Events.

On March 12, 2024, Sharecare, Inc. (the “Company”) issued a press release providing a strategic update. Also on March 12, 2024, the Company issued a press release announcing that it has rescheduled the issuance of its fourth quarter and full year 2023 earnings release and investor conference to March 28, 2024.

A copy of the press releases are attached hereto as Exhibits 99.1 and 99.2, respectively and are incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Description
99.1
99.2
104Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SHARECARE, INC.

Dated: March 12, 2024
By: /s/ Colin Daniel
Name: Colin Daniel
Title: Chief Administrative Officer



 EX-99.1 2 strategicalternatives.htm EX-99.1 Document

image1.jpg


Sharecare provides strategic update

Independent special committee of the Sharecare Board of Directors reviewing
multiple proposals

ATLANTA – March 12, 2024 – Sharecare (Nasdaq: SHCR) has been evaluating a range of options including a potential sale of the Company, as well as a reevaluation of potential carveout divestitures and an assessment of Sharecare’s strategic direction and continuation as a standalone public company.

Sharecare has been interacting with interested parties, and the Board of Directors formed a special committee of independent directors to evaluate multiple proposals for a potential sale transaction and alternatives thereto. Financial and legal advisors have been retained to assist in the evaluation process.

“Given the disconnect between Sharecare’s stock price and the intrinsic value of our company, we believe engaging with parties who have expressed interest in acquiring us is a prudent approach in our efforts to maximize value for our shareholders,” said Jeff Arnold, executive chairman and founder of Sharecare. “The board is committed to taking whatever action is in the best interests of shareholders while management continues to be fully committed to the satisfaction of our customers and executing on our strategy and growth plans.”

No definitive decisions have been reached regarding strategic alternatives and there is no assurance if or when a transaction may occur. Sharecare will provide an update during its earnings call scheduled for Thursday, March 28, 2024.

About Sharecare
Sharecare is the leading digital health company that helps people – no matter where they are in their health journey – unify and manage all their health in one place. Our comprehensive and data-driven virtual health platform is designed to help people, providers, employers, health plans, government organizations, and communities optimize individual and population-wide well-being by driving positive behavior change. Driven by our philosophy that we are all together better, at Sharecare, we are committed to supporting each individual through the lens of their personal health and making high-quality care more accessible and affordable for everyone. To learn more, visit www.sharecare.com.

Important Notice Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 that are based on beliefs and assumptions and on information currently available. In some cases, you can identify forward-looking statements by the following words: “outlook,” “target,” “reflect,” “on track,” “foresees,” “future,” “may,” “deliver,” “will,” “shall,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing” or the negative of these terms, other comparable terminology (although not all forward-looking statements contain these words), or by discussions of strategy, plans, or intentions. These statements involve risks,


uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain.

Forward-looking statements in this press release include, but are not limited to, statements regarding the strategic review and the evaluation of proposals for a sale transaction and other strategic alternatives.

We cannot assure you that the forward-looking statements in this press release will prove to be accurate. These forward-looking statements are subject to a number of significant risks and uncertainties that could cause actual results to differ materially from expected results. Descriptions of some of the factors that could cause actual results to differ materially from these forward-looking statements are discussed in more detail in our filings with the U.S. Securities and Exchange Commission (the “SEC“), including the Risk Factors section of the Company’s Annual Report on Form 10-K filed with the SEC on March 31, 2023. Furthermore, if the forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. The forward-looking statements in this press release represent our views as of the date of this press release. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this press release.


Media Relations: pr@sharecare.com

Investor Relations: investors@sharecare.com

EX-99.2 3 earningsreschedule.htm EX-99.2 Document



image.jpg


Sharecare reschedules issuance of fourth quarter and full year
2023 earnings release and investor conference call

ATLANTA – March 12, 2024 – Sharecare (Nasdaq: SHCR), the digital health company that helps people manage all their health in one place, today announced that it has postponed the release of its financial results and conference call related to the fourth quarter and full year ended December 31, 2023, which had previously been scheduled for March 13, 2024.

Sharecare expects to issue its fourth quarter and full year 2023 financial results after market close on Thursday, March 28, 2024, and hold its conference call on the same day at 4:30 p.m. EDT.

In connection with this postponement, the Company will file a Form 12b-25 with the Securities and Exchange Commission to disclose that it will not be able to file its Form 10-K by its due date of March 15, 2024, but it is expected to do so within the 15-day extension period allowed by the Form. For the avoidance of doubt, the Company does not currently expect any changes to previously reported financials.

About Sharecare
Sharecare is the leading digital health company that helps people – no matter where they are in their health journey – unify and manage all their health in one place. Our comprehensive and data-driven virtual health platform is designed to help people, providers, employers, health plans, government organizations, and communities optimize individual and population-wide well-being by driving positive behavior change. Driven by our philosophy that we are all together better, at Sharecare, we are committed to supporting each individual through the lens of their personal health and making high-quality care more accessible and affordable for everyone. To learn more, visit www.sharecare.com.

Important Notice Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 that are based on beliefs and assumptions and on information currently available. In some cases, you can identify forward-looking statements by the following words: “outlook,” “target,” “reflect,” “on track,” “foresees,” “future,” “may,” “deliver,” “will,” “shall,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing” or the negative of these terms, other comparable terminology (although not all forward-looking statements contain these words), or by discussions of strategy, plans, or intentions. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain.





Forward-looking statements in this press release include, but are not limited to, statements regarding the issuance of fourth quarter and full year 2023 financial results and previously reported financials.

We cannot assure you that the forward-looking statements in this press release will prove to be accurate. These forward-looking statements are subject to a number of significant risks and uncertainties that could cause actual results to differ materially from expected results. Descriptions of some of the factors that could cause actual results to differ materially from these forward-looking statements are discussed in more detail in our filings with the U.S. Securities and Exchange Commission (the “SEC“), including the Risk Factors section of the Company’s Annual Report on Form 10-K filed with the SEC on March 31, 2023. Furthermore, if the forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. The forward-looking statements in this press release represent our views as of the date of this press release. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this press release.

Media Relations: pr@sharecare.com

Investor Relations: investors@sharecare.com


 EX-101.SCH 4 shcr-20240312.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 5 shcr-20240312_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 shcr-20240312_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Information [Line Items] Entity Information [Line Items] Document Period End Date Document Period End Date Pre-commencement Tender Offer Pre-commencement Tender Offer Class of Stock [Domain] Class of Stock [Domain] Soliciting Material Soliciting Material City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Central Index Key Entity Central Index Key Entity Address, City or Town Entity Address, City or Town Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Written Communications Written Communications Local Phone Number Local Phone Number Trading Symbol Trading Symbol Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, State or Province Entity Address, State or Province Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Cover [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Common Stock, par value $0.0001 per share Common Class A [Member] Document Type Document Type Amendment Flag Amendment Flag Entity Ex Transition Period Entity Ex Transition Period Class of Stock [Axis] Class of Stock [Axis] Entity File Number Entity File Number Entities [Table] Entities [Table] Entity Tax Identification Number Entity Tax Identification Number Warrants, each warrant exercisable for one share of common stock, each at an exercise price of $11.50 per share Redeemable Warrants [Member] Redeemable Warrants Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Registrant Name Entity Registrant Name EX-101.PRE 7 shcr-20240312_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 8 image.jpg begin 644 image.jpg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end GRAPHIC 9 image1.jpg begin 644 image1.jpg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end XML 10 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover
Mar. 12, 2024
Entity Information [Line Items]  
Document Type 8-K
Document Period End Date Mar. 12, 2024
Entity Registrant Name SHARECARE, INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-39535
Entity Tax Identification Number 85-1365053
Entity Address, Address Line One 255 East Paces Ferry Road NE
Entity Address, Address Line Two Suite 700
Entity Address, City or Town Atlanta
Entity Address, State or Province GA
Entity Address, Postal Zip Code 30305
City Area Code 404
Local Phone Number 671-4000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity Central Index Key 0001816233
Amendment Flag false
Common Stock, par value $0.0001 per share  
Entity Information [Line Items]  
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol SHCR
Security Exchange Name NASDAQ
Warrants, each warrant exercisable for one share of common stock, each at an exercise price of $11.50 per share  
Entity Information [Line Items]  
Title of 12(b) Security Warrants, each warrant exercisable for one share of common stock, each at an exercise price of $11.50 per share
Trading Symbol SHCRW
Security Exchange Name NASDAQ
EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 13 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 16 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 3 24 1 false 2 0 false 0 false false R1.htm 0000001 - Document - Cover Sheet http://www.sharecare.com/role/Cover Cover Cover 1 false false All Reports Book All Reports shcr-20240312.htm shcr-20240312.xsd shcr-20240312_def.xml shcr-20240312_lab.xml shcr-20240312_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 18 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "shcr-20240312.htm": { "nsprefix": "shcr", "nsuri": "http://www.sharecare.com/20240312", "dts": { "inline": { "local": [ "shcr-20240312.htm" ] }, "schema": { "local": [ "shcr-20240312.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "definitionLink": { "local": [ "shcr-20240312_def.xml" ] }, "labelLink": { "local": [ "shcr-20240312_lab.xml" ] }, "presentationLink": { "local": [ "shcr-20240312_pre.xml" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 1, "memberCustom": 1, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 3, "entityCount": 1, "segmentCount": 2, "elementCount": 31, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 27 }, "report": { "R1": { "role": "http://www.sharecare.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "shcr-20240312.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "shcr-20240312.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "us-gaap_CommonClassAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonClassAMember", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock, par value $0.0001 per share", "label": "Common Class A [Member]" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitiesTable", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entities [Table]", "label": "Entities [Table]", "documentation": "Container to assemble all relevant information about each entity associated with the document instance" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Ex Transition Period", "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInformationLineItems", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Information [Line Items]", "label": "Entity Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "shcr_RedeemableWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.sharecare.com/20240312", "localname": "RedeemableWarrantsMember", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants, each warrant exercisable for one share of common stock, each at an exercise price of $11.50 per share", "label": "Redeemable Warrants [Member]", "documentation": "Redeemable Warrants" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.sharecare.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 19 0001816233-24-000064-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001816233-24-000064-xbrl.zip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shcr-20240312_htm.xml IDEA: XBRL DOCUMENT 0001816233 2024-03-12 2024-03-12 0001816233 us-gaap:CommonClassAMember 2024-03-12 2024-03-12 0001816233 shcr:RedeemableWarrantsMember 2024-03-12 2024-03-12 0001816233 false 8-K 2024-03-12 SHARECARE, INC. DE 001-39535 85-1365053 255 East Paces Ferry Road NE Suite 700 Atlanta GA 30305 404 671-4000 false false false false Common Stock, par value $0.0001 per share SHCR NASDAQ Warrants, each warrant exercisable for one share of common stock, each at an exercise price of $11.50 per share SHCRW NASDAQ true false